Chronic Inflammatory Demyelinating Polyneuropathy clinical trials

Explore recruiting chronic inflammatory demyelinating polyneuropathy clinical trials.

Recruiting chronic inflammatory demyelinating polyneuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Inflammatory Demyelinating Polyneuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Croatia, Belgium, France, Italy, Germany, Spain +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-label Extension of the ARGX-113-1802 Trial to Investigate the Longterm Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Austria, Netherlands, Italy, Belgium, France, Romania +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants with Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sweden, Spain, Norway, Germany, Denmark, Poland +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, multicenter, open-label, non-randomized, proof-of-concept study evaluating the efficacy, safety, and tolerability of SAR445088 in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)

Poland, Germany, France, Spain, Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Italy, Greece, Czechia, Poland, Germany, France +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Czechia, Denmark, Poland, Slovenia, Netherlands, Austria +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Inflammatory Demyelinating Polyneuropathy trials by city

Chronic Inflammatory Demyelinating Polyneuropathy in Toronto Chronic Inflammatory Demyelinating Polyneuropathy in Vancouver Chronic Inflammatory Demyelinating Polyneuropathy in Montreal Chronic Inflammatory Demyelinating Polyneuropathy in Calgary Chronic Inflammatory Demyelinating Polyneuropathy in Edmonton Chronic Inflammatory Demyelinating Polyneuropathy in Ottawa Chronic Inflammatory Demyelinating Polyneuropathy in Winnipeg Chronic Inflammatory Demyelinating Polyneuropathy in Quebec City Chronic Inflammatory Demyelinating Polyneuropathy in Hamilton Chronic Inflammatory Demyelinating Polyneuropathy in Kitchener Chronic Inflammatory Demyelinating Polyneuropathy in London Chronic Inflammatory Demyelinating Polyneuropathy in Halifax Chronic Inflammatory Demyelinating Polyneuropathy in New York Chronic Inflammatory Demyelinating Polyneuropathy in Los Angeles Chronic Inflammatory Demyelinating Polyneuropathy in Chicago Chronic Inflammatory Demyelinating Polyneuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease